Share on Pinterest A new trial finds that GLP-1 agonists may help reduce knee osteoarthritis-related pain. Westend61/Getty ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As weight loss medications like Ozempic continue to gain traction for their ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

"Obesity-related knee osteoarthritis is a progressive condition that can lead to pain and stiffness of the knee and impair ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Recent research has found that semaglutide injections, which also include controversial weight loss drug Ozempic, can reduce ...

1, 2024 (HealthDay News) -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who received weekly injections of semaglutide -- the ...

Do you suffer from knee pain during or after movement? Does knee pain limit your mobility or prevent you from enjoying some activities you previously found joy in? There is mounting evidence that ...